GlassScriptPhysician profile
Matthew Nwosu
NPI 1073776563
$519.44
in general payments reported to CMS, 2019-2025
11 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $84.18 · 2023: $189 · 2024: $105 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $142.58 | 2023 | Acessa Provu System |
| Exeltis, USA INC. | $73.73 | 2025 | Slynd |
| Abbvie INC. | $67.28 | 2022 | |
| Coopersurgical, INC. | $56.86 | 2022-2025 | Paragard T 380a |
| Applied Medical Resources Corporation | $52.55 | 2024 | Gelpoint V-Path |
| Mayne Pharma Commercial LLC | $29.29 | 2025 | |
| Astellas Pharma US INC | $23.96 | 2023 | Myrbetriq |
| W. L. Gore & Associates, INC. | $22.19 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Millicent US INC | $19.48 | 2024 | Femring, Intrarosa |
| Minerva Surgical, INC | $15.81 | 2025 | |
| Pfizer INC. | $15.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Nwosu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.